Reconstitution Required: Bacteriostatic Water needed for research peptide preparation (not for human use)

Theramedix Retatrutide is a synthetic investigational peptide that has been widely discussed in scientific literature for its unique multi-receptor interaction profile.

Retatrutide is studied as a triple-receptor agonist, interacting with GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.

In research settings, this multi-pathway interaction has made Retatrutide a subject of interest in studies examining energy balance, metabolic signaling, and regulatory pathway modeling. Its structural design differentiates it from single- or dual-receptor peptides discussed in current scientific literature.

Any references to receptor activity or metabolic pathways are provided solely for educational and laboratory contextand do not imply therapeutic outcomes.

This material is provided exclusively for laboratory research, analytical study, and in-vitro investigation.

Not for human or clinical use. For research use only.